|
1
|
Lee SH, Kwon JE and Cho ML: Immunological
pathogenesis of inflammatory bowel disease. Intest Res. 16:26–42.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Mattos BR, Garcia MP, Nogueira JB,
Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM
and Simioni PU: Inflammatory bowel disease: An overview of immune
mechanisms and biological treatments. Mediators Inflamm.
2015:4930122015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dalal SR and Kwon JH: The role of MicroRNA
in inflammatory bowel disease. Gastroenterol Hepatol (NY).
6:714–722. 2010.
|
|
4
|
Chapman CG and Pekow J: The emerging role
of miRNAs in inflammatory bowel disease: A review. Therap Adv
Gastroenterol. 8:4–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu XM and Zhang HJ: miRNAs as new
molecular insights into inflammatory bowel disease: Crucial
regulators in autoimmunity and inflammation. World J Gastroenterol.
22:2206–2218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schaefer JS, Attumi T, Opekun AR, Abraham
B, Hou J, Shelby H, Graham DY, Streckfus C and Klein JR: MicroRNA
signatures differentiate Crohn's disease from ulcerative colitis.
BMC Immunol. 16:52015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalla R, Ventham NT, Kennedy NA, Quintana
JF, Nimmo ER, Buck AH and Satsangi J: MicroRNAs: New players in
IBD. Gut. 64:504–517. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adams AT, Kennedy NA, Hansen R, Ventham
NT, O'Leary KR, Drummond HE, Noble CL, El-Omar E, Russell RK,
Wilson DC, et al: Two-stage genome-wide methylation profiling in
childhood-onset Crohn's disease implicates epigenetic alterations
at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis. 20:1784–1793.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu F, Dong F, Arendovich N, Zhang J, Huang
Y and Kwon JH: Divergent influence of microRNA-21 deletion on
murine colitis phenotypes. Inflamm Bowel Dis. 20:1972–1985. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brain O, Owens BM, Pichulik T, Allan P,
Khatamzas E, Leslie A, Steevels T, Sharma S, Mayer A, Catuneanu AM,
et al: The intracellular sensor NOD2 induces microRNA-29 expression
in human dendritic cells to limit IL-23 release. Immunity.
39:521–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wehkamp J, Harder J, Weichenthal M, Schwab
M, Schäffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F,
Fritz P, et al: NOD2 (CARD15) mutations in Crohn's disease are
associated with diminished mucosal alpha-defensin expression. Gut.
53:1658–1664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brest P, Lapaquette P, Souidi M, Lebrigand
K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF,
Hébuterne X, et al: A synonymous variant in IRGM alters a binding
site for miR-196 and causes deregulation of IRGM-dependent
xenophagy in Crohn's disease. Nat Genet. 43:242–245. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghorpade DS, Sinha AY, Holla S, Singh V
and Balaji KN: NOD2-nitric oxide-responsive microRNA-146a activates
Sonic hedgehog signaling to orchestrate inflammatory responses in
murine model of inflammatory bowel disease. J Biol Chem.
288:33037–33048. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He X, Jing Z and Cheng G: MicroRNAs: New
regulators of Toll-like receptor signalling pathways. Biomed Res
Int. 2014:9451692014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu MT and Coca-Prados M: Electron
microscopic evidence for the circular form of RNA in the cytoplasm
of eukaryotic cells. Nature. 280:339–340. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harvey RF and Bradshaw JM: A simple index
of Crohn's-disease activity. Lancet. 1:5141980. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Satsangi J, Silverberg MS, Vermeire S and
Colombel JF: The Montreal classification of inflammatory bowel
disease: Controversies, consensus, and implications. Gut.
55:749–753. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L, Guo J, Chen Y, Chang C and Xu C:
Comprehensive CircRNA expression profile and selection of key
CircRNAs during priming phase of rat liver regeneration. BMC
Genomics. 18:802017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
The Gene Ontology Consortium: Expansion of
the gene ontology knowledgebase and resources. Nucleic Acids Res.
45:D331–D338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jeck WR and Sharpless NE: Detecting and
characterizing circular RNAs. Nat Biotechnol. 32:453–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang K, Long B, Liu F, Wang JX, Liu CY,
Zhao B, Zhou LY, Sun T, Wang M, Yu T, et al: A circular RNA
protects the heart from pathological hypertrophy and heart failure
by targeting miR-223. Eur Heart J. 37:2602–2611. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lukiw WJ: Circular RNA (circRNA) in
Alzheimer's disease (AD). Front Genet. 4:3072013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Q, Zhang X, Hu X, Dai L, Fu X, Zhang J
and Ao Y: Circular RNA related to the chondrocyte ECM regulates
MMP13 expression by functioning as a MiR-136 ‘Sponge’ in human
cartilage degradation. Sci Rep. 6:225722016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nata T, Fujiya M, Ueno N, Moriichi K,
Konishi H, Tanabe H, Ohtake T, Ikuta K and Kohgo Y: MicroRNA-146b
improves intestinal injury in mouse colitis by activating nuclear
factor-kappaB and improving epithelial barrier function. J Gene
Med. 15:249–260. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fasseu M, Tréton X, Guichard C, Pedruzzi
E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC,
Moreau R, et al: Identification of restricted subsets of mature
microRNA abnormally expressed in inactive colonic mucosa of
patients with inflammatory bowel disease. PLoS One. 5:e131602010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhernakova A, Festen EM, Franke L, Trynka
G, van Diemen CC, Monsuur AJ, Bevova M, Nijmeijer RM, van 't Slot
R, Heijmans R, et al: Genetic analysis of innate immunity in
Crohn's disease and ulcerative colitis identifies two
susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet.
82:1202–1210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Catarzi S, Marcucci T, Papucci L, Favilli
F, Donnini M, Tonelli F, Vincenzini MT and Iantomasi T: Apoptosis
and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn's disease
patients. Inflamm Bowel Dis. 14:819–825. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sartor RB: Mechanisms of disease:
Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin
Pract Gastroenterol Hepatol. 3:390–407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Diegelmann J, Czamara D, Le Bras E,
Zimmermann E, Olszak T, Bedynek A, Göke B, Franke A, Glas J and
Brand S: Intestinal DMBT1 expression is modulated by Crohn's
disease-associated IL23R variants and by a DMBT1 variant which
influences binding of the transcription factors CREB1 and ATF-2.
PLoS One. 8:e777732013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shen J, Qiao Y, Ran Z and Wang T:
Different activation of TRAF4 and TRAF6 in inflammatory bowel
disease. Mediators Inflamm. 2013:6479362013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nunes T, Bernardazzi C and de Souza HS:
Cell death and inflammatory bowel diseases: Apoptosis, necrosis,
and autophagy in the intestinal epithelium. Biomed Res Int.
2014:2184932014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mudter J and Neurath MF: Apoptosis of T
cells and the control of inflammatory bowel disease: Therapeutic
implications. Gut. 56:293–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cario E: Toll-like receptors in
inflammatory bowel diseases: A decade later. Inflamm Bowel Dis.
16:1583–1597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Goretsky T, Dirisina R, Sinh P, Mittal N,
Managlia E, Williams DB, Posca D, Ryu H, Katzman RB and Barrett TA:
p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am J
Pathol. 181:1306–1315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ireton RC and Gale M Jr: RIG-I like
receptors in antiviral immunity and therapeutic applications.
Viruses. 3:906–919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Singh UP, Singh NP, Murphy EA, Price RL,
Fayad R, Nagarkatti M and Nagarkatti PS: Chemokine and cytokine
levels in inflammatory bowel disease patients. Cytokine. 77:44–49.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Terzić J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology.
138:2101–2114.e5. 2010. View Article : Google Scholar : PubMed/NCBI
|
